<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30081498</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Aug</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hedgehog Signaling Pathway and Autophagy in Cancer.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">2279</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms19082279</ELocationID>
        <Abstract>
          <AbstractText>Hedgehog (Hh) pathway controls complex developmental processes in vertebrates. Abnormal activation of Hh pathway is responsible for tumorigenesis and maintenance of multiple cancers, and thus addressing this represents promising therapeutic opportunities. In recent years, two Hh inhibitors have been approved for basal cell carcinoma (BCC) treatment and show extraordinary clinical outcomes. Meanwhile, a series of novel agents are being developed for the treatment of several cancers, including lung cancer, leukemia, and pancreatic cancer. Unfortunately, Hh inhibition fails to show satisfactory benefits in these cancer types compared with the success stories in BCC, highlighting the need for better understanding of Hh signaling in cancer. Autophagy, a conserved biological process for cellular component elimination, plays critical roles in the initiation, progression, and drug resistance of cancer, and therefore, implied potential to be targeted. Recent evidence demonstrated that Hh signaling interplays with autophagy in multiple cancers. Importantly, modulating this crosstalk exhibited noteworthy capability to sensitize primary and drug-resistant cancer cells to Hh inhibitors, representing an emerging opportunity to reboot the efficacy of Hh inhibition in those insensitive tumors, and to tackle drug resistance challenges. This review will highlight recent advances of Hh pathway and autophagy in cancers, and focus on their crosstalk and the implied therapeutic opportunities.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Xian</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiological and Biochemical Pharmacy &amp; The Key Laboratory of Smart Drug Delivery MOE, School of Pharmacy, Fudan University, Shanghai 201203, China. zengxian@u.nus.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore 117543, Singapore. zengxian@u.nus.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ju</LastName>
            <ForeName>Dianwen</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiological and Biochemical Pharmacy &amp; The Key Laboratory of Smart Drug Delivery MOE, School of Pharmacy, Fudan University, Shanghai 201203, China. dianwenju@fudan.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">autophagy</Keyword>
        <Keyword MajorTopicYN="N">cancer therapy</Keyword>
        <Keyword MajorTopicYN="N">crosstalk</Keyword>
        <Keyword MajorTopicYN="N">drug combination</Keyword>
        <Keyword MajorTopicYN="N">drug resistance</Keyword>
        <Keyword MajorTopicYN="N">hedgehog</Keyword>
        <Keyword MajorTopicYN="N">precision medicine</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30081498</ArticleId>
        <ArticleId IdType="pmc">PMC6121518</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms19082279</ArticleId>
        <ArticleId IdType="pii">ijms19082279</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nusslein-Volhard C., Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287:795–801. doi: 10.1038/287795a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/287795a0</ArticleId>
            <ArticleId IdType="pubmed">6776413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 2001;15:3059–3087. doi: 10.1101/gad.938601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.938601</ArticleId>
            <ArticleId IdType="pubmed">11731473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324–331. doi: 10.1038/nature03100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03100</ArticleId>
            <ArticleId IdType="pubmed">15549094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrova R., Joyner A.L. Roles for Hedgehog signaling in adult organ homeostasis and repair. Development. 2014;141:3445–3457. doi: 10.1242/dev.083691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.083691</ArticleId>
            <ArticleId IdType="pmc">PMC4197719</ArticleId>
            <ArticleId IdType="pubmed">25183867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briscoe J., Therond P.P. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 2013;14:416–429. doi: 10.1038/nrm3598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3598</ArticleId>
            <ArticleId IdType="pubmed">23719536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xin M., Ji X., De La Cruz L.K., Thareja S., Wang B. Strategies to target the Hedgehog signaling pathway for cancer therapy. Med. Res. Rev. 2018;38:870–913. doi: 10.1002/med.21482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/med.21482</ArticleId>
            <ArticleId IdType="pubmed">29315702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Von Hoff D.D., LoRusso P.M., Rudin C.M., Reddy J.C., Yauch R.L., Tibes R., Weiss G.J., Borad M.J., Hann C.L., Brahmer J.R., et al.  Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 2009;361:1164–1172. doi: 10.1056/NEJMoa0905360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa0905360</ArticleId>
            <ArticleId IdType="pubmed">19726763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudin C.M., Hann C.L., Laterra J., Yauch R.L., Callahan C.A., Fu L., Holcomb T., Stinson J., Gould S.E., Coleman B., et al.  Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 2009;361:1173–1178. doi: 10.1056/NEJMoa0902903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa0902903</ArticleId>
            <ArticleId IdType="pmc">PMC5317279</ArticleId>
            <ArticleId IdType="pubmed">19726761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoRusso P.M., Rudin C.M., Reddy J.C., Tibes R., Weiss G.J., Borad M.J., Hann C.L., Brahmer J.R., Chang I., Darbonne W.C., et al.  Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin. Cancer Res. 2011;17:2502–2511. doi: 10.1158/1078-0432.CCR-10-2745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-10-2745</ArticleId>
            <ArticleId IdType="pmc">PMC5244484</ArticleId>
            <ArticleId IdType="pubmed">21300762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim E.J., Sahai V., Abel E.V., Griffith K.A., Greenson J.K., Takebe N., Khan G.N., Blau J.L., Craig R., Balis U.G., et al.  Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma. Clin. Cancer Res. 2014;20:5937–5945. doi: 10.1158/1078-0432.CCR-14-1269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-14-1269</ArticleId>
            <ArticleId IdType="pmc">PMC4254161</ArticleId>
            <ArticleId IdType="pubmed">25278454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catenacci D.V., Junttila M.R., Karrison T., Bahary N., Horiba M.N., Nattam S.R., Marsh R., Wallace J., Kozloff M., Rajdev L., et al.  Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. J. Clin. Oncol. 2015;33:4284–4292. doi: 10.1200/JCO.2015.62.8719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2015.62.8719</ArticleId>
            <ArticleId IdType="pmc">PMC4678179</ArticleId>
            <ArticleId IdType="pubmed">26527777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharpe H.J., Pau G., Dijkgraaf G.J., Basset-Seguin N., Modrusan Z., Januario T., Tsui V., Durham A.B., Dlugosz A.A., Haverty P.M., et al.  Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 2015;27:327–341. doi: 10.1016/j.ccell.2015.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2015.02.001</ArticleId>
            <ArticleId IdType="pmc">PMC5675004</ArticleId>
            <ArticleId IdType="pubmed">25759019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buonamici S., Williams J., Morrissey M., Wang A., Guo R., Vattay A., Hsiao K., Yuan J., Green J., Ospina B., et al.  Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci. Transl. Med. 2010;2:51ra70. doi: 10.1126/scitranslmed.3001599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3001599</ArticleId>
            <ArticleId IdType="pmc">PMC3422576</ArticleId>
            <ArticleId IdType="pubmed">20881279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu L., Chen Y., Tooze S.A. Autophagy pathway: Cellular and molecular mechanisms. Autophagy. 2018;14:207–215. doi: 10.1080/15548627.2017.1378838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2017.1378838</ArticleId>
            <ArticleId IdType="pmc">PMC5902171</ArticleId>
            <ArticleId IdType="pubmed">28933638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santana-Codina N., Mancias J.D., Kimmelman A.C. The Role of Autophagy in Cancer. Annu. Rev. Cancer Biol. 2017;1:19–39. doi: 10.1146/annurev-cancerbio-041816-122338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-cancerbio-041816-122338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy J.M.M., Towers C.G., Thorburn A. Targeting autophagy in cancer. Nat. Rev. Cancer. 2017;17:528–542. doi: 10.1038/nrc.2017.53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc.2017.53</ArticleId>
            <ArticleId IdType="pmc">PMC5975367</ArticleId>
            <ArticleId IdType="pubmed">28751651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ClinicalTrials.gov.  [(accessed on 1 July 2018)]; Available online:  https://clinicaltrials.gov/</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Y., Ding Q., Yen C.J., Xia W., Izzo J.G., Lang J.Y., Li C.W., Hsu J.L., Miller S.A., Wang X., et al.  The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012;21:374–387. doi: 10.1016/j.ccr.2011.12.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2011.12.028</ArticleId>
            <ArticleId IdType="pmc">PMC3350095</ArticleId>
            <ArticleId IdType="pubmed">22439934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramaswamy B., Lu Y., Teng K.Y., Nuovo G., Li X., Shapiro C.L., Majumder S. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Cancer Res. 2012;72:5048–5059. doi: 10.1158/0008-5472.CAN-12-1248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-1248</ArticleId>
            <ArticleId IdType="pmc">PMC3837449</ArticleId>
            <ArticleId IdType="pubmed">22875023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ke Z., Caiping S., Qing Z., Xiaojing W. Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway. Med. Oncol. 2015;32:368. doi: 10.1007/s12032-014-0368-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12032-014-0368-y</ArticleId>
            <ArticleId IdType="pubmed">25432698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao G., Pedone C.A., del Valle L., Reiss K., Holland E.C., Fults D.W. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene. 2004;23:6156–6162. doi: 10.1038/sj.onc.1207818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1207818</ArticleId>
            <ArticleId IdType="pubmed">15195141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S., Andre J., Alexaki I., Li A., Magnaldo T., ten Dijke P., Wang X.J., Verrecchia F., Mauviel A. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 2007;67:6981–6986. doi: 10.1158/0008-5472.CAN-07-0491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-07-0491</ArticleId>
            <ArticleId IdType="pubmed">17638910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji Z., Mei F.C., Xie J., Cheng X. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem. 2007;282:14048–14055. doi: 10.1074/jbc.M611089200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M611089200</ArticleId>
            <ArticleId IdType="pubmed">17353198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajurkar M., de Jesus-Monge W.E., Driscoll D.R., Appleman V.A., Huang H., Cotton J.L., Klimstra D.S., Zhu L.J., Simin K., Xu L., et al.  The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis. Proc. Natl. Acad. Sci. USA. 2012;109:E1038–E1047. doi: 10.1073/pnas.1114168109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1114168109</ArticleId>
            <ArticleId IdType="pmc">PMC3340052</ArticleId>
            <ArticleId IdType="pubmed">22493246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu M., Ingram L., Tolosa E.J., Vera R.E., Li Q., Kim S., Ma Y., Spyropoulos D.D., Beharry Z., Huang J., et al.  Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis. J. Biol. Chem. 2016;291:25749–25760. doi: 10.1074/jbc.M116.753129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M116.753129</ArticleId>
            <ArticleId IdType="pmc">PMC5207270</ArticleId>
            <ArticleId IdType="pubmed">27760825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regan J.L., Schumacher D., Staudte S., Steffen A., Haybaeck J., Keilholz U., Schweiger C., Golob-Schwarzl N., Mumberg D., Henderson D., et al.  Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells. Cell Rep. 2017;21:2813–2828. doi: 10.1016/j.celrep.2017.11.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.11.025</ArticleId>
            <ArticleId IdType="pubmed">29212028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao S., Shah A.S., Moninger T.O., Ostedgaard L.S., Lu L., Tang X.X., Thornell I.M., Reznikov L.R., Ernst S.E., Karp P.H., et al.  Motile cilia of human airway epithelia contain hedgehog signaling components that mediate noncanonical hedgehog signaling. Proc. Natl. Acad. Sci. USA. 2018;115:1370–1375. doi: 10.1073/pnas.1719177115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1719177115</ArticleId>
            <ArticleId IdType="pmc">PMC5819449</ArticleId>
            <ArticleId IdType="pubmed">29358407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blotta S., Jakubikova J., Calimeri T., Roccaro A.M., Amodio N., Azab A.K., Foresta U., Mitsiades C.S., Rossi M., Todoerti K., et al.  Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma. Blood. 2012;120:5002–5013. doi: 10.1182/blood-2011-07-368142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-07-368142</ArticleId>
            <ArticleId IdType="pmc">PMC3525024</ArticleId>
            <ArticleId IdType="pubmed">22821765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beauchamp E.M., Ringer L., Bulut G., Sajwan K.P., Hall M.D., Lee Y.C., Peaceman D., Ozdemirli M., Rodriguez O., Macdonald T.J., et al.  Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J. Clin. Investig. 2011;121:148–160. doi: 10.1172/JCI42874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI42874</ArticleId>
            <ArticleId IdType="pmc">PMC3007144</ArticleId>
            <ArticleId IdType="pubmed">21183792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J., Lee J.J., Kim J., Gardner D., Beachy P.A. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl. Acad. Sci. USA. 2010;107:13432–13437. doi: 10.1073/pnas.1006822107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1006822107</ArticleId>
            <ArticleId IdType="pmc">PMC2922148</ArticleId>
            <ArticleId IdType="pubmed">20624968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J., Tang J.Y., Gong R., Kim J., Lee J.J., Clemons K.V., Chong C.R., Chang K.S., Fereshteh M., Gardner D., et al.  Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell. 2010;17:388–399. doi: 10.1016/j.ccr.2010.02.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2010.02.027</ArticleId>
            <ArticleId IdType="pmc">PMC4039177</ArticleId>
            <ArticleId IdType="pubmed">20385363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Q., Hou Y.C., Huang J., Fang J.Y., Xiong H. Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells. J. Exp. Clin. Cancer Res. 2017;36:50. doi: 10.1186/s13046-017-0526-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-017-0526-0</ArticleId>
            <ArticleId IdType="pmc">PMC5387201</ArticleId>
            <ArticleId IdType="pubmed">28399898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J., Aftab B.T., Tang J.Y., Kim D., Lee A.H., Rezaee M., Kim J., Chen B., King E.M., Borodovsky A., et al.  Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell. 2013;23:23–34. doi: 10.1016/j.ccr.2012.11.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2012.11.017</ArticleId>
            <ArticleId IdType="pmc">PMC3548977</ArticleId>
            <ArticleId IdType="pubmed">23291299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowles D.W., Keysar S.B., Eagles J.R., Wang G., Glogowska M.J., McDermott J.D., Le P.N., Gao D., Ray C.E., Rochon P.J., et al.  A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol. 2016;53:74–79. doi: 10.1016/j.oraloncology.2015.11.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.oraloncology.2015.11.014</ArticleId>
            <ArticleId IdType="pmc">PMC5676309</ArticleId>
            <ArticleId IdType="pubmed">26705064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybstein M.D., Bravo-San Pedro J.M., Kroemer G., Galluzzi L. The autophagic network and cancer. Nat. Cell Biol. 2018;20:243–251. doi: 10.1038/s41556-018-0042-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41556-018-0042-2</ArticleId>
            <ArticleId IdType="pubmed">29476153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., Mazure N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 2009;29:2570–2581. doi: 10.1128/MCB.00166-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00166-09</ArticleId>
            <ArticleId IdType="pmc">PMC2682037</ArticleId>
            <ArticleId IdType="pubmed">19273585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X., Li Y., Fan J., Zhao H., Xian Z., Sun Y., Wang Z., Wang S., Zhang G., Ju D. Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin’s lymphoma cells. Cell Death Dis. 2013;4:e840. doi: 10.1038/cddis.2013.359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2013.359</ArticleId>
            <ArticleId IdType="pmc">PMC3824669</ArticleId>
            <ArticleId IdType="pubmed">24113174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song P., Ye L., Fan J., Li Y., Zeng X., Wang Z., Wang S., Zhang G., Yang P., Cao Z., et al.  Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells. Oncotarget. 2015;6:3861–3873. doi: 10.18632/oncotarget.2869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.2869</ArticleId>
            <ArticleId IdType="pmc">PMC4414159</ArticleId>
            <ArticleId IdType="pubmed">25738356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X., Chen W., Fan J., Wang S., Xian Z., Luan J., Li Y., Wang Y., Nan Y., Luo M., et al.  Disrupting CD47-SIRPalpha axis alone or combined with autophagy depletion for the therapy of glioblastoma. Carcinogenesis. 2018;39:689–699. doi: 10.1093/carcin/bgy041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/carcin/bgy041</ArticleId>
            <ArticleId IdType="pubmed">29538621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Wang S., Wang Z., Qian X., Fan J., Zeng X., Sun Y., Song P., Feng M., Ju D. Cationic poly(amidoamine) dendrimers induced cyto-protective autophagy in hepatocellular carcinoma cells. Nanotechnology. 2014;25:365101. doi: 10.1088/0957-4484/25/36/365101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1088/0957-4484/25/36/365101</ArticleId>
            <ArticleId IdType="pubmed">25140534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shibutani S.T., Saitoh T., Nowag H., Munz C., Yoshimori T. Autophagy and autophagy-related proteins in the immune system. Nat. Immunol. 2015;16:1014–1024. doi: 10.1038/ni.3273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3273</ArticleId>
            <ArticleId IdType="pubmed">26382870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong Z.Y., Sanchez-Lopez E., Karin M. Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment. Cell. 2016;166:288–298. doi: 10.1016/j.cell.2016.05.051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.05.051</ArticleId>
            <ArticleId IdType="pmc">PMC4947210</ArticleId>
            <ArticleId IdType="pubmed">27419869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marinković M., Šprung M., Buljubašić M., Novak I. Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy. Oxid. Med. Cell. Longev. 2018;2018:1–18. doi: 10.1155/2018/8023821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/8023821</ArticleId>
            <ArticleId IdType="pmc">PMC5831833</ArticleId>
            <ArticleId IdType="pubmed">29643976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ko A., Kanehisa A., Martins I., Senovilla L., Chargari C., Dugue D., Marino G., Kepp O., Michaud M., Perfettini J.L., et al.  Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ. 2014;21:92–99. doi: 10.1038/cdd.2013.124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2013.124</ArticleId>
            <ArticleId IdType="pmc">PMC3857616</ArticleId>
            <ArticleId IdType="pubmed">24037090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michaud M., Martins I., Sukkurwala A.Q., Adjemian S., Ma Y.T., Pellegatti P., Shen S.S., Kepp O., Scoazec M., Mignot G., et al.  Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice. Science. 2011;334:1573–1577. doi: 10.1126/science.1208347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1208347</ArticleId>
            <ArticleId IdType="pubmed">22174255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brechbiel J., Miller-Moslin K., Adjei A.A. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Cancer Treat. Rev. 2014;40:750–759. doi: 10.1016/j.ctrv.2014.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ctrv.2014.02.003</ArticleId>
            <ArticleId IdType="pubmed">24613036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandolfi S., Stecca B. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: Implications for cancer therapy. Expert Rev. Mol. Med. 2015;17:e5. doi: 10.1017/erm.2015.3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/erm.2015.3</ArticleId>
            <ArticleId IdType="pmc">PMC4836208</ArticleId>
            <ArticleId IdType="pubmed">25660620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rovida E., Stecca B. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? Semin. Cancer Biol. 2015;35:154–167. doi: 10.1016/j.semcancer.2015.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcancer.2015.08.003</ArticleId>
            <ArticleId IdType="pubmed">26292171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jimenez-Sanchez M., Menzies F.M., Chang Y.Y., Simecek N., Neufeld T.P., Rubinsztein D.C. The Hedgehog signalling pathway regulates autophagy. Nat. Commun. 2012;3:1200. doi: 10.1038/ncomms2212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms2212</ArticleId>
            <ArticleId IdType="pmc">PMC3514496</ArticleId>
            <ArticleId IdType="pubmed">23149744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kouroku Y., Fujita E., Tanida I., Ueno T., Isoai A., Kumagai H., Ogawa S., Kaufman R.J., Kominami E., Momoi T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007;14:230–239. doi: 10.1038/sj.cdd.4401984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.cdd.4401984</ArticleId>
            <ArticleId IdType="pubmed">16794605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rouschop K.M.A., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., Keulers T., Mujcic H., Landuyt W., Voncken J.W., et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Investig. 2010;120:127–141. doi: 10.1172/JCI40027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI40027</ArticleId>
            <ArticleId IdType="pmc">PMC2798689</ArticleId>
            <ArticleId IdType="pubmed">20038797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 2003;422:313–317. doi: 10.1038/nature01493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01493</ArticleId>
            <ArticleId IdType="pubmed">12629553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., Piccirillo S., Vescovi A.L., DiMeco F., Olivi A., et al.  Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007;25:2524–2533. doi: 10.1634/stemcells.2007-0166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1634/stemcells.2007-0166</ArticleId>
            <ArticleId IdType="pmc">PMC2610257</ArticleId>
            <ArticleId IdType="pubmed">17628016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C., Chen A., Jamieson C.H., Fereshteh M., Abrahamsson A., Blum J., Kwon H.Y., Kim J., Chute J.P., Rizzieri D., et al.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458:776–779. doi: 10.1038/nature07737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07737</ArticleId>
            <ArticleId IdType="pmc">PMC2946231</ArticleId>
            <ArticleId IdType="pubmed">19169242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman D.M., Karhadkar S.S., Hallahan A.R., Pritchard J.I., Eberhart C.G., Watkins D.N., Chen J.K., Cooper M.K., Taipale J., Olson J.M., et al.  Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 2002;297:1559–1561. doi: 10.1126/science.1073733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1073733</ArticleId>
            <ArticleId IdType="pubmed">12202832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J.T., Berman D.M., Beachy P.A. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 2004;431:707–712. doi: 10.1038/nature02962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02962</ArticleId>
            <ArticleId IdType="pubmed">15361885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846–851. doi: 10.1038/nature01972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01972</ArticleId>
            <ArticleId IdType="pubmed">14520411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernández-del C.C., Yajnik V., et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425:851–857. doi: 10.1038/nature02009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02009</ArticleId>
            <ArticleId IdType="pmc">PMC3688051</ArticleId>
            <ArticleId IdType="pubmed">14520413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu J., Rodova M., Roy S.K., Sharma J., Singh K.P., Srivastava R.K., Shankar S. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Cancer Lett. 2013;330:22–32. doi: 10.1016/j.canlet.2012.11.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2012.11.018</ArticleId>
            <ArticleId IdType="pmc">PMC4153855</ArticleId>
            <ArticleId IdType="pubmed">23200667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benvenuto M., Masuelli L., De Smaele E., Fantini M., Mattera R., Cucchi D., Bonanno E., Di Stefano E., Frajese G.V., Orlandi A., et al.  In vitro and in vivo inhibition of breast cancer cell growth by targeting the HedgehogGLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Oncotarget. 2016;7:9250–9270. doi: 10.18632/oncotarget.7062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.7062</ArticleId>
            <ArticleId IdType="pmc">PMC4891038</ArticleId>
            <ArticleId IdType="pubmed">26843616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauth M., Bergstrom A., Shimokawa T., Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA. 2007;104:8455–8460. doi: 10.1073/pnas.0609699104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0609699104</ArticleId>
            <ArticleId IdType="pmc">PMC1866313</ArticleId>
            <ArticleId IdType="pubmed">17494766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Infante P., Mori M., Alfonsi R., Ghirga F., Aiello F., Toscano S., Ingallina C., Siler M., Cucchi D., Po A., et al.  Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO J. 2015;34:200–217. doi: 10.15252/embj.201489213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embj.201489213</ArticleId>
            <ArticleId IdType="pmc">PMC4298015</ArticleId>
            <ArticleId IdType="pubmed">25476449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.J., Perera R.M., Wang H., Wu D.C., Liu X.S., Han S., Fitamant J., Jones P.D., Ghanta K.S., Kawano S., et al.  Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl. Acad. Sci. USA. 2014;111:E3091–E3100. doi: 10.1073/pnas.1411679111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1411679111</ArticleId>
            <ArticleId IdType="pmc">PMC4121834</ArticleId>
            <ArticleId IdType="pubmed">25024225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang X., Deng L., Chen Q., Wang Y., Xu R., Shi C., Shao J., Hu G., Gao M., Rao H., et al.  Inhibition of Hedgehog signaling pathway impedes cancer cell proliferation by promotion of autophagy. Eur. J. Cell Biol. 2015;94:223–233. doi: 10.1016/j.ejcb.2015.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejcb.2015.03.003</ArticleId>
            <ArticleId IdType="pubmed">25824057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Han C., Lu L., Magliato S., Wu T. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells. Hepatology. 2013;58:995–1010. doi: 10.1002/hep.26394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26394</ArticleId>
            <ArticleId IdType="pmc">PMC3706478</ArticleId>
            <ArticleId IdType="pubmed">23504944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Wei S., Zhao Y., Shi C., Liu P., Zhang C., Lei Y., Zhang B., Bai B., Huang Y., et al.  Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death. Cancer Lett. 2017;385:128–136. doi: 10.1016/j.canlet.2016.10.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2016.10.034</ArticleId>
            <ArticleId IdType="pubmed">27810405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villegas V.E., Rondon-Lagos M., Annaratone L., Castellano I., Grismaldo A., Sapino A., Zaphiropoulos P.G. Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling. Int. J. Mol. Sci. 2016;17:308.  doi: 10.3390/ijms17030308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms17030308</ArticleId>
            <ArticleId IdType="pmc">PMC4813171</ArticleId>
            <ArticleId IdType="pubmed">26927093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu R., Li J., Zhang T., Zou L., Chen Y., Wang K., Lei Y., Yuan K., Li Y., Lan J., et al.  Itraconazole suppresses the growth of glioblastoma through induction of autophagy: Involvement of abnormal cholesterol trafficking. Autophagy. 2014;10:1241–1255. doi: 10.4161/auto.28912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.28912</ArticleId>
            <ArticleId IdType="pmc">PMC4203550</ArticleId>
            <ArticleId IdType="pubmed">24905460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang L., Walter V., Hayes D.N., Onaitis M. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer. Clin. Cancer Res. 2014;20:1566–1575. doi: 10.1158/1078-0432.CCR-13-2195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-13-2195</ArticleId>
            <ArticleId IdType="pmc">PMC4136748</ArticleId>
            <ArticleId IdType="pubmed">24423612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pietanza M.C., Litvak A.M., Varghese A.M., Krug L.M., Fleisher M., Teitcher J.B., Holodny A.I., Sima C.S., Woo K.M., Ng K.K., et al.  A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer. Lung Cancer. 2016;99:23–30. doi: 10.1016/j.lungcan.2016.04.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lungcan.2016.04.014</ArticleId>
            <ArticleId IdType="pmc">PMC5427482</ArticleId>
            <ArticleId IdType="pubmed">27565909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abe Y., Tanaka N. The Hedgehog Signaling Networks in Lung Cancer: The Mechanisms and Roles in Tumor Progression and Implications for Cancer Therapy. BioMed Res. Int. 2016;2016:7969286. doi: 10.1155/2016/7969286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/7969286</ArticleId>
            <ArticleId IdType="pmc">PMC5220431</ArticleId>
            <ArticleId IdType="pubmed">28105432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J.H., Yang H.P., Zhou X.D., Wang H.J., Gong L., Tang C.L. Autophagy Accompanied with Bisdemethoxycurcumin-induced Apoptosis in Non-small Cell Lung Cancer Cells. Biomed. Environ. Sci. 2015;28:105–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25716561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J., Ju D., Li Y., Wang S., Wang Z. A novel approach to overcome non-small-cell lung cancer: Co-inhibition of autophagy and Hedgehog pathway. Ann. Oncol. 2015;26(Suppl. 7):vii106–vii151. doi: 10.1093/annonc/mdv472.04.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/annonc/mdv472.04</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J., Zhang X., Wang S., Chen W., Li Y., Zeng X., Wang Y., Luan J., Li L., Sun X., et al.  Regulating autophagy facilitated therapeutic efficacy of Sonic hedgehog pathway inhibition on lung adenocarcinoma through Gli 2 suppression and ROS production. Cell Death Dis. 2018 under review.</Citation>
        </Reference>
        <Reference>
          <Citation>Amantini C., Morelli M.B., Nabissi M., Cardinali C., Santoni M., Gismondi A., Santoni G. Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner. Oncotarget. 2016;7:50180–50194. doi: 10.18632/oncotarget.10326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.10326</ArticleId>
            <ArticleId IdType="pmc">PMC5226576</ArticleId>
            <ArticleId IdType="pubmed">27367032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y., An Y., Wang X., Zha W., Li X. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells. Oncol. Rep. 2014;31:707–712. doi: 10.3892/or.2013.2881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/or.2013.2881</ArticleId>
            <ArticleId IdType="pubmed">24297612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., Dekleva E.N., Saunders T., Becerra C.P., Tattersall I.W., et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735–747. doi: 10.1016/j.ccr.2014.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.04.021</ArticleId>
            <ArticleId IdType="pmc">PMC4096698</ArticleId>
            <ArticleId IdType="pubmed">24856585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa C.M., Biancur D.E., Wang X., Halbrook C.J., Sherman M.H., Zhang L., Kremer D., Hwang R.F., Witkiewicz A.K., Ying H., et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536:479–483. doi: 10.1038/nature19084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature19084</ArticleId>
            <ArticleId IdType="pmc">PMC5228623</ArticleId>
            <ArticleId IdType="pubmed">27509858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiet T.D., Hopyan S., Nadesan P., Gokgoz N., Poon R., Lin A.C., Yan T., Andrulis I.L., Alman B.A., Wunder J.S. Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am. J. Pathol. 2006;168:321–330. doi: 10.2353/ajpath.2006.050001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2006.050001</ArticleId>
            <ArticleId IdType="pmc">PMC1592680</ArticleId>
            <ArticleId IdType="pubmed">16400033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell V.T., Nadesan P., Ali S.A., Wang C.Y., Whetstone H., Poon R., Wei Q., Keilty J., Proctor J., Wang L.W., et al.  Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth. Mol. Cancer Ther. 2014;13:1259–1269. doi: 10.1158/1535-7163.MCT-13-0731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-13-0731</ArticleId>
            <ArticleId IdType="pubmed">24634412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Y., Guo W., Ren T., Liang W., Zhou W., Lu Q., Jiao G., Yan T. Gli1 inhibition suppressed cell growth and cell cycle progression and induced apoptosis as well as autophagy depending on ERK1/2 activity in human chondrosarcoma cells. Cell Death Dis. 2014;5:e979. doi: 10.1038/cddis.2013.497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2013.497</ArticleId>
            <ArticleId IdType="pmc">PMC4040663</ArticleId>
            <ArticleId IdType="pubmed">24384722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiao G., Ren T., Guo W., Ren C., Yang K. Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy. Tumour Biol. 2015;36:3969–3977. doi: 10.1007/s13277-015-3040-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13277-015-3040-z</ArticleId>
            <ArticleId IdType="pubmed">25577250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zibat A., Missiaglia E., Rosenberger A., Pritchard-Jones K., Shipley J., Hahn H., Fulda S. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene. 2010;29:6323–6330. doi: 10.1038/onc.2010.368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2010.368</ArticleId>
            <ArticleId IdType="pubmed">20818440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nitzki F., Cuvelier N., Drager J., Schneider A., Braun T., Hahn H. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells. Oncogene. 2016;35:2923–2931. doi: 10.1038/onc.2015.346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2015.346</ArticleId>
            <ArticleId IdType="pubmed">26387541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridzewski R., Rettberg D., Dittmann K., Cuvelier N., Fulda S., Hahn H. Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines. Front. Oncol. 2015;5:130. doi: 10.3389/fonc.2015.00130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2015.00130</ArticleId>
            <ArticleId IdType="pmc">PMC4459089</ArticleId>
            <ArticleId IdType="pubmed">26106586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Louis C.U., Shohet J.M. Neuroblastoma: Molecular pathogenesis and therapy. Annu. Rev. Med. 2015;66:49–63. doi: 10.1146/annurev-med-011514-023121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-med-011514-023121</ArticleId>
            <ArticleId IdType="pmc">PMC4418018</ArticleId>
            <ArticleId IdType="pubmed">25386934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang M., Weiss W.A. Neuroblastoma and MYCN. Cold Spring Harb. Perspect. Med. 2013;3:a014415. doi: 10.1101/cshperspect.a014415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a014415</ArticleId>
            <ArticleId IdType="pmc">PMC3784814</ArticleId>
            <ArticleId IdType="pubmed">24086065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yue Z.X., Huang C., Gao C., Xing T.Y., Liu S.G., Li X.J., Zhao Q., Wang X.S., Zhao W., Jin M., et al.  MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma. Cancer Cell. Int. 2017;17:43. doi: 10.1186/s12935-017-0412-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12935-017-0412-z</ArticleId>
            <ArticleId IdType="pmc">PMC5374581</ArticleId>
            <ArticleId IdType="pubmed">28367105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L.S., Wang X.W., Wan J.H., Li T., Gong X.Y., Zhang K., Yi L., Xiang Z.H., Xu M.H., Cui H.J. Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth. Mol. Cell Biochem. 2012;364:235–241. doi: 10.1007/s11010-011-1222-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-011-1222-6</ArticleId>
            <ArticleId IdType="pubmed">22350753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Gu S., Huang J., Chen S., Zhang Z., Xu M. Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells. BMC Cancer. 2014;14:768.  doi: 10.1186/1471-2407-14-768.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2407-14-768</ArticleId>
            <ArticleId IdType="pmc">PMC4210511</ArticleId>
            <ArticleId IdType="pubmed">25323222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Huang S., Tian R., Chen J., Gao H., Xie C., Shan Y., Zhang Z., Gu S., Xu M. The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK. Oncotarget. 2018;9:14413–14427. doi: 10.18632/oncotarget.24214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.24214</ArticleId>
            <ArticleId IdType="pmc">PMC5865679</ArticleId>
            <ArticleId IdType="pubmed">29581853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramaswamy V., Remke M., Bouffet E., Bailey S., Clifford S.C., Doz F., Kool M., Dufour C., Vassal G., Milde T., et al.  Risk stratification of childhood medulloblastoma in the molecular era: The current consensus. Acta Neuropathol. 2016;131:821–831. doi: 10.1007/s00401-016-1569-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-016-1569-6</ArticleId>
            <ArticleId IdType="pmc">PMC4867119</ArticleId>
            <ArticleId IdType="pubmed">27040285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei Y., Liu K.W., Wang J., Garancher A., Tao R., Esparza L.A., Maier D.L., Udaka Y.T., Murad N., Morrissy S., et al.  HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma. Cancer Cell. 2016;29:311–323. doi: 10.1016/j.ccell.2016.02.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2016.02.011</ArticleId>
            <ArticleId IdType="pmc">PMC4794752</ArticleId>
            <ArticleId IdType="pubmed">26977882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaturvedi N.K., Kling M.J., Coulter D.W., McGuire T.R., Ray S., Kesherwani V., Joshi S.S., Sharp J.G. Improved therapy for medulloblastoma: Targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy. Oncotarget. 2018;9:16619–16633. doi: 10.18632/oncotarget.24618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.24618</ArticleId>
            <ArticleId IdType="pmc">PMC5908274</ArticleId>
            <ArticleId IdType="pubmed">29682173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner K., Rothe K., Woolfson A., Jiang X. SMO and GLI2 are key regulators mediating resistance of CML stem/progenitor cells to tyrosine kinase inhibitors. Exp. Hematol. 2017;53:S62. doi: 10.1016/j.exphem.2017.06.109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exphem.2017.06.109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Rothe K., Yen R., Fruhstorfer C., Maetzig T., Chen M., Forrest D.L., Humphries R.K., Jiang X. A novel AHI-1-BCR-ABL-DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy. Leukemia. 2017;31:2376–2387. doi: 10.1038/leu.2017.108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/leu.2017.108</ArticleId>
            <ArticleId IdType="pmc">PMC5668499</ArticleId>
            <ArticleId IdType="pubmed">28366933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amakye D., Jagani Z., Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 2013;19:1410–1422. doi: 10.1038/nm.3389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3389</ArticleId>
            <ArticleId IdType="pubmed">24202394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irvine D.A., Copland M. Targeting hedgehog in hematologic malignancy. Blood. 2012;119:2196–2204. doi: 10.1182/blood-2011-10-383752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-10-383752</ArticleId>
            <ArticleId IdType="pubmed">22223823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X., Zhao H., Li Y., Fan J., Sun Y., Wang S., Wang Z., Song P., Ju D. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Autophagy. 2015;11:355–372. doi: 10.4161/15548627.2014.994368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/15548627.2014.994368</ArticleId>
            <ArticleId IdType="pmc">PMC4502679</ArticleId>
            <ArticleId IdType="pubmed">25701353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J., Zeng X., Li Y., Wang S., Yang P., Cao Z., Wang Z., Song P., Mei X., Ju D. A novel therapeutic approach against B-cell non-Hodgkin’s lymphoma through co-inhibition of Hedgehog signaling pathway and autophagy. Tumour Biol. 2016;37:7305–7314. doi: 10.1007/s13277-015-4614-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13277-015-4614-5</ArticleId>
            <ArticleId IdType="pubmed">26666826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H., Chen Z., Sattva S.N., Jorge R., Nami M. Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment. Oncotarget. 2016;7:14350–14365. doi: 10.18632/oncotarget.7320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.7320</ArticleId>
            <ArticleId IdType="pmc">PMC4924720</ArticleId>
            <ArticleId IdType="pubmed">26885608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J., Wu G., Zeng R., Wang J., Cai R., Ho J.C.-M., Zhang J., Zheng Y. Chromium contributes to human bronchial epithelial cell carcinogenesis by activating Gli2 and inhibiting autophagy. Toxicol. Res. 2017;6:324–332. doi: 10.1039/C6TX00372A.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C6TX00372A</ArticleId>
            <ArticleId IdType="pmc">PMC6060711</ArticleId>
            <ArticleId IdType="pubmed">30090501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Granato M., Zompetta C., Vescarelli E., Rizzello C., Cardi A., Valia S., Antonelli G., Marchese C., Torrisi M.R., Faggioni A., et al.  HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2. Sci. Rep. 2016;6:30649. doi: 10.1038/srep30649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep30649</ArticleId>
            <ArticleId IdType="pmc">PMC4967919</ArticleId>
            <ArticleId IdType="pubmed">27476557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X.Y., He Y.J., Yang Q.H., Huang W., Liu Z.H., Ye G.R., Tang S.H., Shu J.C. Induction of autophagy and apoptosis by miR-148a through the sonic hedgehog signaling pathway in hepatic stellate cells. Am. J. Cancer Res. 2015;5:2569–2589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4633891</ArticleId>
            <ArticleId IdType="pubmed">26609469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J., Zhang L., Xia Q., Fu J., Zhou Z., Lin F. Hedgehog signaling inhibitor GANT61 induces endoplasmic reticulum stress-mediated protective autophagy in hepatic stellate cells. Biochem. Biophys. Res. Commun. 2017;493:487–493. doi: 10.1016/j.bbrc.2017.08.164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2017.08.164</ArticleId>
            <ArticleId IdType="pubmed">28870808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan N.N., Liu X.J., Wu J. Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. Life Sci. 2017;176:42–53. doi: 10.1016/j.lfs.2017.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2017.03.012</ArticleId>
            <ArticleId IdType="pubmed">28322865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deretic V., Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14:243–251. doi: 10.1080/15548627.2017.1402992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2017.1402992</ArticleId>
            <ArticleId IdType="pmc">PMC5902214</ArticleId>
            <ArticleId IdType="pubmed">29165043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saini N.K., Baena A., Ng T.W., Venkataswamy M.M., Kennedy S.C., Kunnath-Velayudhan S., Carreno L.J., Xu J., Chan J., Larsen M.H., et al.  Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47. Nat. Microbiol. 2016;1:16133. doi: 10.1038/nmicrobiol.2016.133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmicrobiol.2016.133</ArticleId>
            <ArticleId IdType="pmc">PMC5662936</ArticleId>
            <ArticleId IdType="pubmed">27562263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roche P.A., Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 2015;15:203–216. doi: 10.1038/nri3818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3818</ArticleId>
            <ArticleId IdType="pmc">PMC6314495</ArticleId>
            <ArticleId IdType="pubmed">25720354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bah A., Vergne I. Macrophage Autophagy and Bacterial Infections. Front. Immunol. 2017;8:1483. doi: 10.3389/fimmu.2017.01483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01483</ArticleId>
            <ArticleId IdType="pmc">PMC5681717</ArticleId>
            <ArticleId IdType="pubmed">29163544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holla S., Kurowska-Stolarska M., Bayry J., Balaji K.N. Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signaling. Autophagy. 2014;10:311–330. doi: 10.4161/auto.27225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.27225</ArticleId>
            <ArticleId IdType="pmc">PMC5396086</ArticleId>
            <ArticleId IdType="pubmed">24343269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milla L.A., Gonzalez-Ramirez C.N., Palma V. Sonic Hedgehog in cancer stem cells: A novel link with autophagy. Biol. Res. 2012;45:223–230. doi: 10.4067/S0716-97602012000300004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4067/S0716-97602012000300004</ArticleId>
            <ArticleId IdType="pubmed">23283432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo Re A.E., Fernandez-Barrena M.G., Almada L.L., Mills L.D., Elsawa S.F., Lund G., Ropolo A., Molejon M.I., Vaccaro M.I., Fernandez-Zapico M.E. Novel AKT1-GLI3-VMP1 pathway mediates KRAS oncogene-induced autophagy in cancer cells. J. Biol. Chem. 2012;287:25325–25334. doi: 10.1074/jbc.M112.370809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.370809</ArticleId>
            <ArticleId IdType="pmc">PMC3408195</ArticleId>
            <ArticleId IdType="pubmed">22535956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. doi: 10.1038/35102167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35102167</ArticleId>
            <ArticleId IdType="pubmed">11689955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clevers H. The cancer stem cell: Premises, promises and challenges. Nat. Med. 2011;17:313–319. doi: 10.1038/nm.2304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2304</ArticleId>
            <ArticleId IdType="pubmed">21386835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beck B., Blanpain C. Unravelling cancer stem cell potential. Nat. Rev. Cancer. 2013;13:727–738. doi: 10.1038/nrc3597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3597</ArticleId>
            <ArticleId IdType="pubmed">24060864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pattabiraman D.R., Weinberg R.A. Tackling the cancer stem cells—What challenges do they pose? Nat. Rev. Drug Discov. 2014;13:497–512. doi: 10.1038/nrd4253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4253</ArticleId>
            <ArticleId IdType="pmc">PMC4234172</ArticleId>
            <ArticleId IdType="pubmed">24981363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh B.N., Fu J., Srivastava R.K., Shankar S. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: Molecular mechanisms. PLoS ONE. 2011;6:e27306.  doi: 10.1371/journal.pone.0027306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0027306</ArticleId>
            <ArticleId IdType="pmc">PMC3210776</ArticleId>
            <ArticleId IdType="pubmed">22087285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063–6071. doi: 10.1158/0008-5472.CAN-06-0054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-0054</ArticleId>
            <ArticleId IdType="pmc">PMC4386278</ArticleId>
            <ArticleId IdType="pubmed">16778178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007;17:165–172. doi: 10.1016/j.cub.2006.11.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cub.2006.11.033</ArticleId>
            <ArticleId IdType="pmc">PMC1855204</ArticleId>
            <ArticleId IdType="pubmed">17196391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Venugopal C., Manoranjan B., McFarlane N., O’Farrell E., Nolte S., Gunnarsson T., Hollenberg R., Kwiecien J., Northcott P., et al.  Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene. 2012;31:187–199. doi: 10.1038/onc.2011.232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2011.232</ArticleId>
            <ArticleId IdType="pubmed">21685941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Po A., Ferretti E., Miele E., de Smaele E., Paganelli A., Canettieri G., Coni S., di Marcotullio L., Biffoni M., Massimi L., et al.  Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J. 2010;29:2646–2658. doi: 10.1038/emboj.2010.131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2010.131</ArticleId>
            <ArticleId IdType="pmc">PMC2928686</ArticleId>
            <ArticleId IdType="pubmed">20581804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong C., Bauvy C., Tonelli G., Yue W., Delomenie C., Nicolas V., Zhu Y., Domergue V., Marin-Esteban V., Tharinger H., et al.  Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 2013;32:2261–2272, 2272e1–11. doi: 10.1038/onc.2012.252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2012.252</ArticleId>
            <ArticleId IdType="pmc">PMC3679409</ArticleId>
            <ArticleId IdType="pubmed">22733132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu H., Wang D., Liu Y., Su Z., Zhang L., Chen F., Zhou Y., Wu Y., Yu M., Zhang Z., et al.  Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells. Cancer Cell. Int. 2013;13:119. doi: 10.1186/1475-2867-13-119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1475-2867-13-119</ArticleId>
            <ArticleId IdType="pmc">PMC4177138</ArticleId>
            <ArticleId IdType="pubmed">24305593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spivak-Kroizman T.R., Hostetter G., Posner R., Aziz M., Hu C., Demeure M.J., Von Hoff D., Hingorani S.R., Palculict T.B., Izzo J., et al.  Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013;73:3235–3247. doi: 10.1158/0008-5472.CAN-11-1433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-11-1433</ArticleId>
            <ArticleId IdType="pmc">PMC3782107</ArticleId>
            <ArticleId IdType="pubmed">23633488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H.J., Li J.J., Li Y.N., Singh P., Cao L., Xu L.J., Li D., Wang Y.B., Xie Z.P., Gui Y., et al.  Sonic hedgehog promotes autophagy of vascular smooth muscle cells. Am. J. Physiol.-Heart C. 2012;303:H1319–H1331. doi: 10.1152/ajpheart.00160.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00160.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3532542</ArticleId>
            <ArticleId IdType="pubmed">23023870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gagne-Sansfacon J., Allaire J.M., Jones C., Boudreau F., Perreault N. Loss of Sonic hedgehog leads to alterations in intestinal secretory cell maturation and autophagy. PLoS ONE. 2014;9:e98751.  doi: 10.1371/journal.pone.0098751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0098751</ArticleId>
            <ArticleId IdType="pmc">PMC4041759</ArticleId>
            <ArticleId IdType="pubmed">24887421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Q., Yang Y., Qin Y., He Y.H., Chen K.X., Zhu J.W., Zhang G.P., Luo J.D. AMP-activated protein kinase-dependent autophagy mediated the protective effect of sonic hedgehog pathway on oxygen glucose deprivation-induced injury of cardiomyocytes. Biochem. Biophys. Res. Commun. 2015;457:419–425. doi: 10.1016/j.bbrc.2015.01.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2015.01.006</ArticleId>
            <ArticleId IdType="pubmed">25582777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petralia R.S., Schwartz C.M., Wang Y.X., Kawamoto E.M., Mattson M.P., Yao P.J. Sonic hedgehog promotes autophagy in hippocampal neurons. Biol. Open. 2013;2:499–504. doi: 10.1242/bio.20134275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/bio.20134275</ArticleId>
            <ArticleId IdType="pmc">PMC3654269</ArticleId>
            <ArticleId IdType="pubmed">23789099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Won K.Y., Kim G.Y., Lim S.J., Sung J.Y., Kim Y.W., Park Y.K., Lee J., Choi H.S. Autophagy is related to the hedgehog signaling pathway in human gastric adenocarcinoma: Prognostic significance of Beclin-1 and Gli2 expression in human gastric adenocarcinoma. Pathol. Res. Pract. 2015;211:308–315. doi: 10.1016/j.prp.2014.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prp.2014.11.005</ArticleId>
            <ArticleId IdType="pubmed">25512258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins F.S., Varmus H. A new initiative on precision medicine. N. Engl. J. Med. 2015;372:793–795. doi: 10.1056/NEJMp1500523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMp1500523</ArticleId>
            <ArticleId IdType="pmc">PMC5101938</ArticleId>
            <ArticleId IdType="pubmed">25635347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebovitz C.B., DeVorkin L., Bosc D., Rothe K., Singh J., Bally M., Jiang X., Young R.N., Lum J.J., Gorski S.M. Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines? Autophagy. 2015;11:1949–1952. doi: 10.1080/15548627.2015.1078962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2015.1078962</ArticleId>
            <ArticleId IdType="pmc">PMC4824567</ArticleId>
            <ArticleId IdType="pubmed">26506897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bortnik S., Gorski S.M. Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers. Int. J. Mol. Sci. 2017;18:1496.  doi: 10.3390/ijms18071496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18071496</ArticleId>
            <ArticleId IdType="pmc">PMC5535986</ArticleId>
            <ArticleId IdType="pubmed">28696368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.M., Huang S., Wu T.T., Foster N.R., Sinicrope F.A. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol. Ther. 2013;14:100–107. doi: 10.4161/cbt.22954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cbt.22954</ArticleId>
            <ArticleId IdType="pmc">PMC3571991</ArticleId>
            <ArticleId IdType="pubmed">23192274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S., Jiang Y.Z., Huang L., Zhou R.J., Yu K.D., Liu Y., Shao Z.M. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy. Clin. Cancer Res. 2013;19:6853–6862. doi: 10.1158/1078-0432.CCR-13-1617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-13-1617</ArticleId>
            <ArticleId IdType="pubmed">24141623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou J., Hang D., Jiang Y., Chen J., Han J., Zhou W., Jin G., Ma H., Dai J. Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer. Gene. 2017;627:549–555. doi: 10.1016/j.gene.2017.06.053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gene.2017.06.053</ArticleId>
            <ArticleId IdType="pubmed">28669927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang D.Y., Ellis R.A., Lovat P.E. Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma. Front. Oncol. 2016;6:236. doi: 10.3389/fonc.2016.00236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2016.00236</ArticleId>
            <ArticleId IdType="pmc">PMC5101199</ArticleId>
            <ArticleId IdType="pubmed">27882308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H., Lu X., Wang N., Wang J., Cao Y., Wang T., Zhou X., Jiao Y., Yang L., Wang X., et al.  Autophagy-related gene expression is an independent prognostic indicator of glioma. Oncotarget. 2017;8:60987–61000. doi: 10.18632/oncotarget.17719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.17719</ArticleId>
            <ArticleId IdType="pmc">PMC5617400</ArticleId>
            <ArticleId IdType="pubmed">28977840</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
